Recent LIPO News
- Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on “Global Transformation in Oral Medicine” • GlobeNewswire Inc. • 04/23/2025 12:30:00 PM
- Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025 • GlobeNewswire Inc. • 04/22/2025 09:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2025 10:08:26 AM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/10/2025 12:43:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2025 09:06:44 PM
- Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus • GlobeNewswire Inc. • 04/08/2025 09:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2025 11:16:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2025 10:05:16 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/04/2025 09:14:41 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/04/2025 08:06:15 PM
- Lipella Pharmaceuticals Co-Founder Michael Chancellor Featured on the Pharmaverse Podcast • GlobeNewswire Inc. • 03/31/2025 03:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/28/2025 10:21:40 AM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/19/2025 10:23:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2025 09:01:10 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/18/2025 12:18:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2025 12:12:52 AM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/12/2025 12:09:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2025 12:01:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2025 09:26:29 PM
- Spartan Capital Securities, LLC Announces Key February Transactions • GlobeNewswire Inc. • 03/07/2025 09:56:47 PM
- Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $3,788,000 Private Placement • GlobeNewswire Inc. • 03/04/2025 06:18:32 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/03/2025 10:01:33 PM
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement • COEP • Apr 25, 2025 8:33 AM
UAV Corp. Successfully Completes Inflation Test of DART SA-70 Airship, Paving Way for Flight Readiness • UMAV • Apr 24, 2025 8:30 AM
InnerScope Hearing Technologies (OTC: INND) Announces the Grand Opening of OTCHealthMart.com • INND • Apr 24, 2025 8:00 AM
Opus Holdings Unveils Powerhouse Leadership Team to Drive Aggressive Growth and Transform Market Trajectory • CATV • Apr 22, 2025 8:30 AM
Glidelogic Corp. (OTCQB: GDLG) Highlights Independent SOTA Evaluation of ResearchMind Platform • GDLG • Apr 22, 2025 6:54 AM
UAV Corp to Launch Inflation Test of SA-70 Airship This Week-A Gateway to High-Value Government and Defense Contracts • UMAV • Apr 21, 2025 1:30 PM